For anyone in Cixi trying to locate CJC-1295, the foundational reality is that this compound is available only through an online research supply market. This global online supply model is ultimately a quality advantage — top vendors differentiate through analytical documentation in ways local stores never could. A properly operating CJC-1295 supplier's COA needs to show HPLC purity, mass spectrometry confirmation of molecular identity, bacterial endotoxin testing, and a residual solvents panel — all corresponding to the vial you receive. Use this guide to evaluate CJC-1295 vendors rigorously — the quality evaluation approach outlined here work regardless of your location.
CJC-1295 Mechanisms Explained
The selectivity profile of different GHS compounds is a critical research consideration. GHRP-6 and GHRP-2 produce GH release alongside cortisol and prolactin elevation — a confounding factor in research designs where these hormones are outcome variables. Ipamorelin was specifically developed for greater GH-release selectivity with minimal cortisol and prolactin elevation, making it more suitable for research designs where GH-specific effects need to be isolated. Hexarelin has the strongest GH-releasing potency in the GHRP class but also the most significant cortisol and prolactin effects. For Cixi researchers designing GH-axis studies, compound selection based on this selectivity profile should precede protocol finalization.
Sourcing Research-Grade CJC-1295
The first step for any Cixi researcher sourcing CJC-1295 is locating suppliers that experienced researchers actively recommend — commercial rankings reflect SEO budgets rather than product quality. Endotoxin testing in the COA is non-negotiable for any injectable research use — endotoxins from microbial contamination can trigger serious immune reactions even at very low concentrations. Signs of a credible vendor beyond COA quality: multi-year operating history, responsive technical support who understand testing methodology, and shipping with desiccant and appropriate cold protection. The lyophilised (freeze-dried) form of CJC-1295 is much more stable than liquid pre-made solutions — lyophilised powder maintains stability for years when frozen, while liquid preparations degrade within weeks even when refrigerated.
Order CJC-1295 — ships to Cixi
COA-verified · International tracking · Research grade
CJC-1295 operates beyond the scope of approved drug regulation — researchers should understand that the known safety profile is based on academic studies rather than pharmaceutical approval data. Storage requirements for CJC-1295: lyophilised powder at freezer temperature, reconstituted solution refrigerated at 2-8°C and used within 30 days; reconstitute only with bac water. Endotoxin testing in the CJC-1295 COA is non-negotiable — gram-negative bacterial endotoxins can trigger severe inflammatory responses at trace quantities, and no discount compensates for this missing data. Protocol documentation — keeping clear records of compound, timing, and method — is a fundamental research principle that ensures unusual findings can be explained.
Frequently Asked Questions
What is the difference between CJC-1295 with DAC and without DAC?
CJC-1295 with DAC uses a lysine-maleimide conjugate to bind covalently to albumin in the bloodstream, extending half-life to ~6-8 days and creating sustained GH elevation. CJC-1295 without DAC (also called Mod GRF 1-29) has a half-life of ~30 minutes and produces acute GH pulses. They produce different GH secretion patterns and have different applications in research.
What purity is required for CJC-1295 research?
CJC-1295 should be ≥98% pure by HPLC. The larger molecular weight of CJC-1295 with DAC (approximately 3647 Da) makes mass spectrometry confirmation particularly important, as impurities may not be obvious on HPLC alone.
What is CJC-1295?
CJC-1295 is a synthetic GHRH (Growth Hormone Releasing Hormone) analogue. The version with DAC (Drug Affinity Complex) has an extended half-life of approximately 6-8 days due to albumin binding. Without DAC, CJC-1295 has a much shorter half-life similar to native GHRH. Both versions stimulate pulsatile GH release via the GHRH receptor.
